Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: microRNA-193a-3p is specifically down-regulated and acts as a tumor suppressor in BRAF-mutated colorectal cancer

Fig. 2

Validation of the miRNAs dysregulated in BRAF-mutant tumors, in another set of patients with colorectal cancer. The expression levels of the five miRNAs were validated in a different set including KRAS/BRAF-wild-type (n = 30) and BRAF-mutant colorectal cancers (n = 4). KRAS-mutant cancers (n = 20) and adjacent normal mucosa (n = 11) were additionally analyzed for the five miRNA expression. Mann-Whitney U test was used to analyze statistical differences

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us